NERRAG annual meeting, 18th October 2017, Lumley Castle Conference Centre, Chester-le-Street, County Durham
| 1400 | Reception/Exhibition |
| 1430 | Welcome-Andy James |
| FIRST SESSION. CHAIR- Tim Cheetham | |
| 1445 | Training update Dr Srikanth Mada TPD HEENE |
| 1500 | “Roadmap towards Harmonisation of Thyroid function reference ranges in the Northumbria and Tyne and Wear areas – how do we get there?” Salman Razvi, E Robinson, C Boot, S Pearce, D Neely, D Kennedy. QEH, RVI and Northumbria.
|
| 1515 | Prevalence of and factors predicting thyroid dysfunction at the time of ST- and non-ST- elevation myocardial infarction – the ThyrAMI 1 study. Avais Jabbar, L Ingoe, A Zaman, S Razvi. QEH, Gateshead, Newcastle Hospitals FT and Newcastle University
|
| 1530 | The diurnal variation of serum thyroid stimulating hormone in patients with acute myocardial infarction. Owain Leng, Jabbar, L Ingoe, H Thomas, S Junejo, P Carey, D Austin, P Bijsterveld, J Greenwood, A Zaman, S Razvi. City Hospitals Sunderland, QEH, Gateshead, Newcastle Hospitals FT and Newcastle University
|
| 1545 | Normal reference values for thyroid uptake of technetium-99m in a single centre UK population. Mavin Macauley, M Shawgi, A Curry, George Petrides, A James, P Perros. Newcastle Hospitals FT.
|
| 1600 | Audit of thyroid ultrasound and fine needle aspiration at Sunderland Royal Hospital. Harry Tustin & Helen Cocks. City Hospitals Sunderland.
|
| 1615 | A rare metabolic case presenting to Ophthalmology. Mavin Macauley, N De-Alwis, A Joshi. City Hospitals Sunderland. |
| 1630 | Tea/Coffee/Exhibition |
| SECOND SESSION-Speed Data. CHAIR-Shaz Wahid | |
| 1700 | Northern Endocrine Network Update Dr Ashwin Joshi and Colleagues |
| 1720 | A Surgical Cure for Type 1 Diabetes Mellitus? Owain Leng, Asgar Madathil. Northumbria Foundation Trust. |
| 1735 | When simple autoimmune hypothyroidism is not so “simple”. Heggie AJ, Nichols M, Carey P, De-Alwis N, Nayar R, Joshi A. City Hopspitals Sunderland.
|
| 1750 | The relationship between free T4 and thyrotropin receptor antibodies is log-linear and negatively influenced by age and smoking in patients with Graves’ disease. Earn Gan, V Tsatlidis, D Kennedy, S Razvi. QEH, Gateshead Foundation Trust.
|
| 1805 | Tremelimumab-induced Graves’ hyperthyroidism. Earn H Gan, R Plummer, S Pearce, P Perros. Newcastl;e Hospitals FT and Newcastle University
. |
| 1820 | Asymptomatic secretory pheochromocytomas in patients with Neurofibromatosis 1 –Is it time to re-evaluate the role of routine screening? Ahmed Al-Sharefi and S. Nag. James Cook University Hospital.
|
| 1835 | Thanks & Buffet/Exhibition |
Stand space sponsored by: Novartis, Amgen, Sanofi, Kyowa Kirin International, Bayer, Lilly, Boehringer Ingelheim, Novo Nordisk
